Related Experiment Video
Updated: May 10, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Structure-based computational investigation of potential TarA inhibitors in Staphylococcus aureus
Boggarapu Ganesh1, Lalitha Guruprasad2
1School of Chemistry, University of Hyderabad, Hyderabad, 500046, India.
Abstract:
Staphylococcus aureus, a spherical Gram-positive bacterium commonly found to coinhabit humans, can also cause minor skin infections to life-threatening conditions such as pneumonia in individuals with weakened immune systems. The bacterium has developed resistance against conventional antibiotics. This underscores the urgent need for novel therapeutic strategies that act on the cell structure and therefore integrity of the bacterium. Wall teichoic acids (WTAs) are essential anionic glycopolymers covalently anchored to the peptidoglycan layer of Gram-positive bacteria, including S. aureus and are crucial for bacterial survival. The biosynthesis of WTA occurs by a multi-step process in the cytoplasm and proceeds through membrane translocation and incorporation into the cell wall. The earliest and most essential step in this pathway is catalyzed by TarA, which transfers N-acetylglucosamine (GlcNAc) to undecaprenyl phosphate, forming the WTA precursor lipid I. TarA catalyzes the reaction that serves as the first committed step in WTA biosynthesis, without which the entire WTA polymer cannot be constructed or transported. The TarA protein domain has emerged as a promising target for drug development due to its pivotal role in cell wall biosynthesis. We obtained the S. aureus TarA three-dimensional structure from AlphaFold2, performed virtual screening on diverse compound libraries so as to establish their binding to the target protein, which led to the identification of hit compounds with good binding affinity towards TarA domain and involvement of key amino acid residue interactions. This was followed by molecular docking studies, assessment of drug likeness properties of hit compounds and molecular dynamics (MD) simulations of S. aureus TarA-hit molecule complexes using Amber18 bio-simulations package. MD trajectory analysis; root mean square deviation, root mean square fluctuation, hydrogen bonding analysis, solvent accessible surface area, principal component analysis, secondary structure analysis, clustering analysis, free energy landscape, interactive hydrogen bond matrix, binding free energies of the simulated complexes and steered MD simulations were studied. This study resulted in the identification of new hit molecules with a potential to reduce the risk of the S. aureus infections.
Insights
Novel drug candidates targeting Staphylococcus aureus TarA were identified. These compounds show potential for developing new therapies against antibiotic-resistant bacterial infections by disrupting cell wall synthesis.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Staphylococcus aureus poses a significant health threat due to antibiotic resistance.
- Wall teichoic acids (WTAs) are essential for Gram-positive bacterial survival, making their biosynthesis pathway a promising drug target.
- TarA is a critical enzyme initiating WTA precursor synthesis, making it a key target for therapeutic intervention.
Purpose of the Study:
- To identify novel compounds that inhibit the essential S. aureus TarA enzyme.
- To explore the potential of TarA as a drug target for combating antibiotic-resistant S. aureus infections.
Main Methods:
- Obtained the 3D structure of S. aureus TarA using AlphaFold2.
- Performed virtual screening and molecular docking to identify potential hit compounds.
- Conducted molecular dynamics simulations to analyze the binding interactions and stability of TarA-compound complexes.
Main Results:
- Identified several hit compounds with significant binding affinity to the S. aureus TarA domain.
- Key amino acid residue interactions were elucidated, crucial for TarA inhibition.
- Molecular dynamics simulations confirmed the stability and binding efficacy of the identified hit molecules.
Conclusions:
- The S. aureus TarA protein is a viable drug target for developing new antibacterial agents.
- The identified hit molecules represent promising leads for novel therapeutic strategies against S. aureus infections.
- Further development of these compounds could lead to effective treatments for antibiotic-resistant S. aureus.
More Related Videos
08:03A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Related Concept Videos
Staphylococcal Skin Infections
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance